CHURC1-FNTB
MOLECULAR TARGETCHURC1-FNTB readthrough
CHURC1-FNTB (CHURC1-FNTB readthrough) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting CHURC1-FNTB
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Gliotoxin | 0.69 | 1 |
| 2 | Lovastatin | 0.69 | 1 |
About CHURC1-FNTB as a Drug Target
CHURC1-FNTB (CHURC1-FNTB readthrough) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented CHURC1-FNTB interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
CHURC1-FNTB inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.